DalsnaFinance › Analyst accuracy › All targets
Every price target we have verified from published news, newest first: 27 targets from Canaccord Genuity. Each one shows the article it came from and links to its full entry, and is judged on the close on the date it comes due. “At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target.
Showing targets from Canaccord Genuity only. All targets Canaccord Genuity’s record →
to $150 from $205 while maintaining a Buy rating on the stock.
Canaccord downgraded Monday.com Ltd. (NASDAQ:MNDY) from Buy to Hold and lowered its price target to $90 from $115.
Canaccord lowered its price target on Artivion Inc. (NYSE:AORT) to $30 from $40 while maintaining a Buy rating
Canaccord Genuity reiterated a Buy rating and $500 price target on Natera Inc.
Canaccord raised its price target on iRhythm Technologies (NASDAQ:IRTC) to $206 from $196
Canaccord Genuity reiterated a Hold rating and $6.00 price target on Snap Inc
Canaccord raised its price target on Amgen Inc. to $440 from $384 on Tuesday while maintaining a Hold rating following the company's third-quarter results and recent pipeline developments.
Canaccord raised its price target on Waystar Holding (NASDAQ:WAY) to $34 from $33
Canaccord raised its price target on Hinge Health Inc (NYSE:HNGE) to $134 from $105
Canaccord raised its price target on EverQuote (NASDAQ:EVER) to $32 from $28 while maintaining a Buy rating following the company's third-quarter results.
ALNY Maintained by Canaccord Genuity -- Price Target Lowered to $323
Canaccord lowered its price target on Mobileye N.V. shares (NASDAQ:MBLY) to $11.00 from $12.00 while maintaining a Buy rating.
Canaccord reduced its price target to $48 from $66, maintaining a Buy rating, noting delays in product launches as a contributing factor.
Canaccord lowered its price target on Rollins Inc. (NYSE:ROL) to $36 from $45
Canaccord Genuity reiterated a Buy rating and $20.00 price target on AngioDynamics Inc.
Canaccord reiterated a Buy rating and $21.00 price target
Investing.com - Canaccord Genuity reiterated a Buy rating on Oklo Inc. (NYSE:OKLO) stock with a $100.00 price target.
Canaccord lowered its price target on Hillman Solutions Corp. to $13 from $14 while maintaining a Buy rating on the stock.
Canaccord joined in by increasing its price target to $950
Canaccord Genuity lowered its price target on Stryker Corp. (NYSE:SYK) to $385 from $400
Canaccord raised MSTR price target to $175 from $130, Buy, saying the setup has "materially brightened".
Canaccord Genuity raised its price target on Workday Inc. (NASDAQ:WDAY) shares to $225 from $200 while maintaining a Buy rating
Canaccord Genuity also reiterated a Buy rating with a $13.00 price target
Canaccord Genuity Group Boosts Amgen (NASDAQ:AMGN) Price Target to $384.00
ABBV Maintained by Canaccord Genuity -- Price Target Raised to $290
Canaccord Genuity reiterated a Buy rating and $930 price target on Meta Platforms Inc.
Canaccord raises Abbvie stock price target to $282 on growth outlook
Retracted targets, ones we found we had misreported, are not listed here and count toward nothing; each firm's row on the analyst accuracy page lists its own under "Retracted". These are facts about what each firm published, not recommendations from Dalsna Finance.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.